Skip to main content
. 2023 Nov 11;16:3251–3266. doi: 10.2147/CCID.S435795

Figure 5.

Figure 5

Effect of VISPO formulations on the androgenic markers in serum. (A) 5α-reductase expression and (B) dihydrotestosterone (DHT) level. The data were analyzed by independent t-test. ***p<0.001.